TY - JOUR
T1 - Adding increased energy or activity to criterion (A) of the DSM-5 definition of hypomania and mania
T2 - Effect on the diagnoses of 907 patients from the bipolar collaborative network
AU - Fredskild, Mette U.
AU - Mintz, Jim
AU - Frye, Mark A.
AU - McElroy, Susan L.
AU - Nolen, Willem A.
AU - Kupka, Ralph
AU - Grunze, Heinz
AU - Keck, Paul E.
AU - Post, Robert M.
AU - Kessing, Lars V.
AU - Suppes, Trisha
N1 - Funding Information:
Lundbeck. Dr Grunze, in the past 3 years, received hypomania in 908 patients with bipolar Suppes T, Mintz J, McElroy SL, et al. Mixed grants/researchsupport,consultingfees,or disorder evaluated prospectively in the Stanley honoraria from GedeonRichter, Genericon, Janssen Foundation Bipolar Treatment Network: a Cilag, Lundbeck, Otsuka, Pfizer, and Servier. Dr sex-specific phenomenon. Arch Gen Psychiatry. Post has spoken for AstraZeneka, Sunovion, 2005;62(10):1089–1096.PubMed CrossRef Takeda, Validus, Pamlabs, and Janssen. Dr Frye, First MB, Gibbon M, Spitzer RL, et al. Structured in the past 3 years, has received grant research Clinical Interview for DSM-IV Axis I Disorders- support from Assurex Health, Mayo Foundation, Research Version (SCID-I). New York, NY: Medibio; provided consultation for Mayo to Actify Biometrics Research Department, New York Neurotherapies, Allergan, Intra-Cellular Therapies, State Psychiatric Institute; 1996. Janssen,Myriad,Neuralstem,Sunovian,Takeda, 22.American Psychiatric Association. Diagnostic and Teva; received CME/travel reimbursement/ and Statistical Manual for Mental Disorders. honoraria from American Physician Institute, Fourth Edition, Text Revision. Washington, DC: CME Outfitters, and Global Academy for Medical American Psychiatric Association; 2000. Education. Dr Keck, in the past 3 years, has Rush AJ, Gullion CM, Basco MR, et al. The received consulting fees or honoraria from Otsuka/ Inventory of Depressive Symptomatology Lundbeck, Janssen, and Sunovion; and receives (IDS): psychometric properties. Psychol Med. royalties as Section Editor of BipolarDisordersfor 1996;26(3):477–486.PubMedCrossRef UpToDate. Drs Kupka, Nolen, Mintz, and McElroy Trivedi MH, Rush AJ, Ibrahim HM, et al. The report no potential conflicts of interest. Inventory of Depressive Symptomatology, Funding/support:MsFredskildwas supported Clinician Rating (IDS-C) and Self-Report (IDS-bytheDanishAmericanResearchExchange SR), and the Quick Inventory of Depressive (DARE) fellowship, sponsored by the Lundbeck Symptomatology, Clinician Rating (QIDS-C) Foundation, for a research scholarship of 10 patients with mood disorders: a psychometric and Self-Report (QIDS-SR) in public sector
Funding Information:
Ms Fredskild was supported by the Danish American Research Exchange (DARE) fellowship, sponsored by the Lundbeck Foundation, for a research scholarship of 10 months at Stanford University (August 2018 to June 2019)
Funding Information:
Publishedonline:October 29, 2019.attended an editorial board meeting sponsored lifetime diagnosis: findings from the UK Bipolar Authorcontributions:Ms Fredskild and Drs by Sunovion; she received an honorarium as part Disorder Research Network (BDRN) study. Am J of the 2014 Award for Research in Mood Disorders Psychiatry. 2017;174(8):803.PubMed CrossRef Mintz and Suppes had full access to all the Bipolar given by the American College of Psychiatrists; she American Psychiatric Association. Diagnostic Collaborative Network data in the study and take performed a medical records review for the law and Statistical Manual for Mental Disorders. responsibility for the integrity ofthe data and the offices of Hughes Socol Piers Resnick and Dym; and Fourth Edition. Washington, DC: American accuracyofthedataanalysis. she was principal investigator and coinvestigator Psychiatric Association; 1994. Potential conflicts of interest: Ms Fredskild on research studies sponsored by NIMH. Leverich GS, Nolen WA, Rush AJ, et al. The was supported by a research scholarship Stanley Foundation Bipolar Treatment (DARE fellowship) sponsored by the Lundbeck Outcome Network, I: longitudinal Foundation. Dr Suppes has in the past 36 months methodology. J Affect Disord. reported grants from National Institutes of Health, 2001;67(1–3):33–44.PubMed CrossRef NationalInstituteofMentalHealth,National 17. Post RM, Leverich GS, Altshuler LL, et al. An Institute on Drug Abuse, Palo Alto Health Sciences, overview of recent findings of the Stanley Institute, VA Cooperative Studies Program, PathwaysGenomics,StanleyMedicalResearch Foundation Bipolar Network (Part I). Bipolar
Publisher Copyright:
© 2019 Physicians Postgraduate Press, Inc.
PY - 2019
Y1 - 2019
N2 - Objective: According to DSM-IV, criterion (A) for diagnosing a hypomanic/manic episode is mood change (ie, elevated, expansive, or irritable mood). Criterion (A) was redefined in DSM-5, adding increased energy or activity in addition to mood change. We sought to investigate the effect of adding increased energy or activity to criterion (A) for the diagnosis of hypomania/mania and, thus, bipolar disorder. Methods: This analysis of prospectively collected data from the Bipolar Collaborative Network (1995-2002) includes 907 DSM-IV-TR-diagnosed bipolar outpatients (14,306 visits). The Young Mania Rating Scale (YMRS) was administered monthly and used to define DSM-IV and DSM-5 criterion (A) fulfillment during a hypomanic/manic visit. Results: Patients were adults (median age = 40; IQR, 33-49), and over half (56%) were women. Median number of contributed visits was 10 (IQR, 4-23). Applying DSM-5 criterion (A) reduced the number of patients experiencing a hypomanic/ manic visit by 34%, compared to DSM-IV. Visits fulfilling DSM-5 criterion (A) had higher odds of experiencing elevated levels of all other mania symptoms, compared to fulfilling DSM-IV criterion (A) only. Association between individual symptoms was strongest with mood elevation and energy or activity (OR [95% CL] = 8.65, [7.91, 9.47]). Conclusions: The 34% reduction in the number of patients being diagnosed with a hypomanic/manic visit shows that the impact of applying DSM-5 criterion (A) is substantial. Fewer hypomanic/manic episodes may be diagnosed by the stricter DSM-5 criterion (A), but the episodes diagnosed are likely to be more severe. The DSM-5 criteria may in general prevent overdiagnosis of bipolar disorder but possibly at the cost of underdiagnosing hypomanic/manic episodes.
AB - Objective: According to DSM-IV, criterion (A) for diagnosing a hypomanic/manic episode is mood change (ie, elevated, expansive, or irritable mood). Criterion (A) was redefined in DSM-5, adding increased energy or activity in addition to mood change. We sought to investigate the effect of adding increased energy or activity to criterion (A) for the diagnosis of hypomania/mania and, thus, bipolar disorder. Methods: This analysis of prospectively collected data from the Bipolar Collaborative Network (1995-2002) includes 907 DSM-IV-TR-diagnosed bipolar outpatients (14,306 visits). The Young Mania Rating Scale (YMRS) was administered monthly and used to define DSM-IV and DSM-5 criterion (A) fulfillment during a hypomanic/manic visit. Results: Patients were adults (median age = 40; IQR, 33-49), and over half (56%) were women. Median number of contributed visits was 10 (IQR, 4-23). Applying DSM-5 criterion (A) reduced the number of patients experiencing a hypomanic/ manic visit by 34%, compared to DSM-IV. Visits fulfilling DSM-5 criterion (A) had higher odds of experiencing elevated levels of all other mania symptoms, compared to fulfilling DSM-IV criterion (A) only. Association between individual symptoms was strongest with mood elevation and energy or activity (OR [95% CL] = 8.65, [7.91, 9.47]). Conclusions: The 34% reduction in the number of patients being diagnosed with a hypomanic/manic visit shows that the impact of applying DSM-5 criterion (A) is substantial. Fewer hypomanic/manic episodes may be diagnosed by the stricter DSM-5 criterion (A), but the episodes diagnosed are likely to be more severe. The DSM-5 criteria may in general prevent overdiagnosis of bipolar disorder but possibly at the cost of underdiagnosing hypomanic/manic episodes.
UR - http://www.scopus.com/inward/record.url?scp=85074367900&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074367900&partnerID=8YFLogxK
U2 - 10.4088/JCP.19m12834
DO - 10.4088/JCP.19m12834
M3 - Article
C2 - 31665571
AN - SCOPUS:85074367900
SN - 0160-6689
VL - 80
JO - Diseases of the Nervous System
JF - Diseases of the Nervous System
IS - 6
M1 - 19m12834
ER -